PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsPurple Biotech
Purple Biotech(PPBT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ConsensiCelecoxib, Amlodipine besylate2018-05-312029-2038
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Osteoarthritis
,
Adenomatous polyposis coli
,
Dysmenorrhea
,
Hypertension
,
Coronary artery disease
,
Variant angina pectoris
,
Pain
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Gilvetmab
neoplasms
,
squamous cell carcinoma of head and neck
,
carcinoma
,
colorectal neoplasms
,
glioblastoma
,
esophageal squamous cell carcinoma
,
astrocytoma
,
hepatocellular carcinoma
,
liver neoplasms
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
sarcoma
,
small cell lung carcinoma
,
malignant mesothelioma
,
neuroendocrine tumors
,
neuroendocrine carcinoma
,
squamous cell neoplasms
,
mesothelioma
,
colonic neoplasms
,
neoplasm metastasis
,
spinocerebellar degenerations
Xenograft
head and neck neoplasms
,
squamous cell carcinoma of head and neck
NT-219
head and neck neoplasms
,
squamous cell carcinoma of head and neck
Mk3475
pancreatic neoplasms
,
neoplasm metastasis
,
squamous cell carcinoma of head and neck
,
transitional cell carcinoma
,
breast neoplasms
,
ovarian neoplasms
,
urologic neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
pelvic neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
melanoma
,
stomach neoplasms
,
triple negative breast neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
prostatic neoplasms
,
invasive hydatidiform mole
,
neoplasms
,
urinary bladder neoplasms
,
adenocarcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use